JP2013515486A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515486A5
JP2013515486A5 JP2012546229A JP2012546229A JP2013515486A5 JP 2013515486 A5 JP2013515486 A5 JP 2013515486A5 JP 2012546229 A JP2012546229 A JP 2012546229A JP 2012546229 A JP2012546229 A JP 2012546229A JP 2013515486 A5 JP2013515486 A5 JP 2013515486A5
Authority
JP
Japan
Prior art keywords
antigen
antibody
binding fragment
ser
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012546229A
Other languages
English (en)
Japanese (ja)
Other versions
JP6000855B2 (ja
JP2013515486A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/061987 external-priority patent/WO2011079257A2/en
Publication of JP2013515486A publication Critical patent/JP2013515486A/ja
Publication of JP2013515486A5 publication Critical patent/JP2013515486A5/ja
Application granted granted Critical
Publication of JP6000855B2 publication Critical patent/JP6000855B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012546229A 2009-12-24 2010-12-23 ヒトアンギオポエチン様タンパク質４に対するヒト抗体 Expired - Fee Related JP6000855B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US29009209P 2009-12-24 2009-12-24
US61/290,092 2009-12-24
US30635910P 2010-02-19 2010-02-19
US61/306,359 2010-02-19
US32831610P 2010-04-27 2010-04-27
US61/328,316 2010-04-27
US34927310P 2010-05-28 2010-05-28
US61/349,273 2010-05-28
US35612610P 2010-06-18 2010-06-18
US61/356,126 2010-06-18
PCT/US2010/061987 WO2011079257A2 (en) 2009-12-24 2010-12-23 Human antibodies to human angiopoietin-like protein 4

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015096446A Division JP2015145424A (ja) 2009-12-24 2015-05-11 ヒトアンギオポエチン様タンパク質４に対するヒト抗体

Publications (3)

Publication Number Publication Date
JP2013515486A JP2013515486A (ja) 2013-05-09
JP2013515486A5 true JP2013515486A5 (enExample) 2014-02-06
JP6000855B2 JP6000855B2 (ja) 2016-10-05

Family

ID=43629324

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012546229A Expired - Fee Related JP6000855B2 (ja) 2009-12-24 2010-12-23 ヒトアンギオポエチン様タンパク質４に対するヒト抗体
JP2015096446A Pending JP2015145424A (ja) 2009-12-24 2015-05-11 ヒトアンギオポエチン様タンパク質４に対するヒト抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015096446A Pending JP2015145424A (ja) 2009-12-24 2015-05-11 ヒトアンギオポエチン様タンパク質４に対するヒト抗体

Country Status (30)

Country Link
US (2) US8354103B2 (enExample)
EP (1) EP2516466B1 (enExample)
JP (2) JP6000855B2 (enExample)
KR (1) KR101842570B1 (enExample)
CN (1) CN102741284A (enExample)
AR (1) AR079708A1 (enExample)
AU (1) AU2010336369C1 (enExample)
BR (1) BR112012017765A2 (enExample)
CA (1) CA2785158C (enExample)
CY (1) CY1118898T1 (enExample)
DK (1) DK2516466T3 (enExample)
ES (1) ES2628135T3 (enExample)
HR (1) HRP20170524T1 (enExample)
HU (1) HUE034722T2 (enExample)
IL (1) IL220402A (enExample)
JO (1) JO3274B1 (enExample)
LT (1) LT2516466T (enExample)
MX (1) MX337082B (enExample)
NZ (1) NZ600768A (enExample)
PL (1) PL2516466T3 (enExample)
PT (1) PT2516466T (enExample)
RS (1) RS56009B1 (enExample)
RU (1) RU2580045C2 (enExample)
SG (1) SG181784A1 (enExample)
SI (1) SI2516466T1 (enExample)
SM (1) SMT201700280T1 (enExample)
TW (1) TWI488643B (enExample)
UY (1) UY33144A (enExample)
WO (1) WO2011079257A2 (enExample)
ZA (1) ZA201204507B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3672B1 (ar) 2008-12-15 2020-08-27 Regeneron Pharma أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
DK2668212T3 (en) 2011-01-28 2018-07-02 Saonofi Biotechnology HUMAN ANTIBODIES AGAINST PCSK9 FOR USE IN PROCEDURES FOR TREATING PARTICULAR GROUPS OF PERSONS
AR087305A1 (es) 2011-07-28 2014-03-12 Regeneron Pharma Formulaciones estabilizadas que contienen anticuerpos anti-pcsk9, metodo de preparacion y kit
EP2758535B1 (en) * 2011-09-19 2016-11-09 Kymab Limited Antibodies, variable domains&chains tailored for human use
CA2870341A1 (en) * 2012-04-13 2013-10-17 The Johns Hopkins University Treatment of ischemic retinopathies
US9255154B2 (en) 2012-05-08 2016-02-09 Alderbio Holdings, Llc Anti-PCSK9 antibodies and use thereof
TW201823460A (zh) 2012-05-29 2018-07-01 美商再生元醫藥公司 生產細胞株增強子
EP2882778B1 (en) 2012-08-13 2018-04-11 Regeneron Pharmaceuticals, Inc. Anti-pcsk9 antibodies with ph-dependent binding characteristics
GB201301313D0 (en) * 2013-01-25 2013-03-06 Univ Singapore Respiratory Tract Infections
BR112015030892A2 (pt) 2013-06-10 2017-08-29 Merck Sharp & Dohme Proteína de ligação ao antígeno, anticorpo monoclonal, ácido nucleico recombinante, vetor de expressão, célula hospedeira, composição farmacêutica, uso de uma proteína de ligação ao antígeno ou anticorpo humanizado, e, método para produzir uma proteína de ligação ao antígeno
KR101538787B1 (ko) * 2013-06-27 2015-07-22 인하대학교 산학협력단 췌장염 진단용 바이오 마커 조성물
EP3092491B1 (en) * 2014-01-07 2018-10-31 Bioatla, LLC Proteins targeting orthologs
WO2016020880A2 (en) * 2014-08-07 2016-02-11 Novartis Ag Angiopoietin-like 4 antibodies and methods of use
WO2016020882A2 (en) * 2014-08-07 2016-02-11 Novartis Ag Angiopoetin-like 4 (angptl4) antibodies and methods of use
US9556225B2 (en) * 2014-10-15 2017-01-31 Uniao Quimica Farmaceutica Nacional S/A Peptide stimulator of cell survival and proliferation
US20180125816A1 (en) 2015-05-11 2018-05-10 Cadila Healthcare Limited Saroglitazar magnesium for the treatment of chylomicronemia syndrome
WO2017011929A1 (zh) * 2015-07-17 2017-01-26 北京大学第一医院 检测血清血管生成素样蛋白2含量的物质在制备检测肝脏炎症和纤维化程度产品中的应用
TW201713690A (zh) 2015-08-07 2017-04-16 再生元醫藥公司 抗ａｎｇｐｔｌ８抗體及其用途
CA2995645A1 (en) 2015-08-18 2017-02-23 Regeneron Pharmaceuticals, Inc. Anti-pcsk9 inhibitory antibodies for treating patients with hyperlipidemia undergoing lipoprotein apheresis
WO2017064635A2 (en) 2015-10-14 2017-04-20 Cadila Healthcare Limited Pyrrole compound, compositions and process for preparation thereof
CN110036029A (zh) 2016-11-17 2019-07-19 瑞泽恩制药公司 用抗angptl8抗体处理肥胖的方法
EP3565598A4 (en) * 2017-01-03 2020-10-28 Trellis Bioscience, LLC NATIVE HUMAN ANTIBODIES FOR TIM-3 AND B7-H3 IMMUNE CHECKPOINT MODULATION TARGETS
US20190031774A1 (en) 2017-06-09 2019-01-31 Sanofi Biotechnology Methods for treating hyperlipidemia in diabetic patients by administering a pcsk9 inhibitor
JP2022525703A (ja) * 2019-03-20 2022-05-18 ジャベリン・オンコロジー・インコーポレイテッド 抗ａｄａｍ１２抗体およびキメラ抗原受容体、ならびにそれを含む組成物および方法
CN113795510A (zh) 2019-08-29 2021-12-14 荣昌生物制药(烟台)股份有限公司 抗pd-l1抗体及其应用
KR20220112290A (ko) * 2019-12-09 2022-08-10 엠피리코 인크. 안지오포이에틴 유사 4(angptl4) 관련 질환의 치료를 위한 올리고뉴클레오타이드
MX2022010537A (es) 2020-02-26 2022-09-21 Vir Biotechnology Inc Anticuerpos contra el coronavirus de tipo 2 causante del sindrome respiratorio agudo severo (sars-cov-2) y metodos de uso de los mismos.
TW202218682A (zh) * 2020-07-02 2022-05-16 美商瑪柏里提克斯公司 細胞結合蛋白及使用方法
WO2022006555A2 (en) * 2020-07-02 2022-01-06 Gigagen, Inc. BISPECIFIC ANTIGEN BINDING PROTEINS TARGETING PD-L1 AND TGF-β AND METHODS OF USE
WO2023239307A1 (en) * 2022-06-10 2023-12-14 Nanyang Technological University Methods of treating liver fibrosis, inflammation or associated diseases using an angptl4 antagonist
AU2023319535A1 (en) * 2022-08-02 2025-02-27 Nona Biosciences (Suzhou) Co., Ltd. Msln antibody-drug conjugate
CN117535353A (zh) * 2023-10-11 2024-02-09 首都医科大学附属北京潞河医院 一种糖尿病视网膜病变模型的建立方法及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7070959B1 (en) 1999-06-08 2006-07-04 Regeneron Pharmaceuticals, Inc. Modified chimeric polypeptides with improved pharmacokinetic properties
US20040101920A1 (en) 2002-11-01 2004-05-27 Czeslaw Radziejewski Modification assisted profiling (MAP) methodology
JP5848861B2 (ja) 2004-04-20 2016-01-27 ジェンマブ エー／エスＧｅｎｍａｂ Ａ／Ｓ Ｃｄ２０に対するヒトモノクローナル抗体
AU2005319382B2 (en) * 2004-12-21 2011-04-07 Astrazeneca Ab Antibodies directed to angiopoietin-2 and uses thereof
JP5366406B2 (ja) * 2005-01-07 2013-12-11 レキシコン ファーマシューティカルズ インコーポレーテッド アンジオポエチン様タンパク質４（ａｎｇｐｔｌ４）に対するモノクローナル抗体
NZ568739A (en) 2005-12-16 2010-09-30 Regeneron Pharma Therapeutic methods for inhibiting tumor growth with delta-like ligand 4 antagonists
EP2007899B1 (en) * 2006-03-20 2017-06-07 Celldex Therapeutics, Inc. Antibodies directed to angiopoietin-like protein 4 and uses thereof
PL2041177T3 (pl) 2006-06-02 2012-09-28 Regeneron Pharma Przeciwciała o wysokim powinowactwie przeciw ludzkiemu receptorowi IL 6
NO347649B1 (no) 2006-12-14 2024-02-12 Regeneron Pharma Humant antistoff eller antistoff fragment som spesifikt binder human deltaliknende ligand 4 (hDII4), nukleinsyremolekyl som koder for slike og vektor og vert-vektorsystemer, samt fremgangsmåte for fremstilling, sammensetning og anvendelse.
JO3672B1 (ar) 2008-12-15 2020-08-27 Regeneron Pharma أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).

Similar Documents

Publication Publication Date Title
JP2013515486A5 (enExample)
RU2012131547A (ru) Антитела человека против ангиопоэтин-подобного белка 4 человека
US11542325B2 (en) Anti-activin A antibodies and uses thereof
RU2013155906A (ru) Антитела анти-angptl3 и их применение
CA2698382C (en) Antigen binding proteins capable of binding thymic stromal lymphopoietin
RU2012156938A (ru) Антитела против gdf8 человека
WO2014144080A2 (en) Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9
RU2014147773A (ru) Человеческие антитела с высокой аффинностью к рецепторам il-4 человека
RU2011129316A (ru) Высокоаффинные человеческие антитела к pcsk9
JP2013542194A5 (enExample)
JP7292526B2 (ja) 操作された抗ｉｌ－２抗体
JP2018510617A5 (enExample)
WO2014150983A2 (en) Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9
JP2016501892A5 (enExample)
JP2015503909A5 (enExample)
RU2019139093A (ru) Фармацевтическая композиция на основе антитела к pd-l1 и ее применение
RU2016122340A (ru) Il-17a-связующий агент и способы его применения
JP6949012B2 (ja) Ｂ型肝炎表面抗原に対する抗体及びその使用
JP2019162119A5 (enExample)
EP2766394A1 (en) Treatment for rheumatoid arthritis
CN111094339A (zh) 抗pd-1抗体和抗lag-3抗体联合在制备治疗肿瘤的药物中的用途
WO2014072741A1 (en) Humanised antibody and method of production thereof
EP3145544A1 (en) Ang2 antibodies
CA2824313A1 (en) Tlr3 binding agents
WO2018080914A1 (en) Anti-rankl antibodies and uses thereof